Reports Outline Familial Mediterranean Fever Study Findings from Sheba Medical Center (Arthroplasty Rates and Risk in Familial Mediterranean Fever Patients: A large Population-Based Study).

A recent study conducted at Sheba Medical Center in Israel has found that patients with Familial Mediterranean Fever (FMF), a genetic disorder characterized by recurrent episodes of fever and inflammation, may be at risk for long-term joint damage that may require surgical joint replacement. The study analyzed data from over 9,000 FMF patients and found that 1.2% of them underwent arthroplasty, compared to 0.7% of the control group. FMF patients of North African origin were found to have a significantly higher risk of arthroplasty. While joint damage is relatively uncommon in FMF patients, it occurs almost twice as frequently as in the general population. [Extracted from the article]